Frequency Therapeutics, co-founded by Robert S. Langer (the David H. Koch Institute Professor at MIT) is a start-up with a platform regenerative technology. Its lead program focused on a breakthrough therapeutic for restoring native hearing in humans. Additional pipeline programs involve GI diseases and diabetes. The laboratory is in the state of the art life science facility being developed by the University of Connecticut in Farmington.

The current Frequency team consist of top notch executives and technologist who previously have worked for the some of the leading pharmaceutical and biotechnology firms in the world. The Frequency work environment is highly collaborative and is managed from an assumption that each team member brings a high level of competency and motivation. This hire will work alongside other top-notch scientists on challenges critical to building a company that can make a substantial impact on human health in the next five years.